• Brenntag Pharma entered an exclusive European distribution partnership with Indovinya for Oxipurity polyethylene glycols and polysorbates.
• Deal expands Brenntag’s excipient portfolio for pharmaceutical, nutraceutical applications across selected markets including France, Italy, Benelux, Nordics.
• Products target broad formulation use, supporting tablets, capsules, oral liquids, topical preparations.
• Oxipurity PEGs manufactured under EXCiPACT GMP certification; polysorbates produced under ANVISA, IPEC-PQG GMP guidance.
• Both product lines comply with EP, USP standards, positioning the partnership to support regulated supply needs in Europe.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Brenntag SE published the original content used to generate this news brief on September 09, 2026, and is solely responsible for the information contained therein.